Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology, 2014 - academic.oup.com
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …
被引用次数：257 相关文章
[HTML] nih.gov

[HTML][HTML] Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology (Oxford, England), 2014 - ncbi.nlm.nih.gov
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology (Oxford, England), 2014 - pubmed.ncbi.nlm.nih.gov
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.

DE Furst, P Emery - Rheumatology, 2014 - search.ebscohost.com
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.

DE Furst, P Emery - Rheumatology (Oxford, England), 2014 - europepmc.org
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology, 2014 - escholarship.org
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

[引用][C] Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology, 2014 - cir.nii.ac.jp
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated
cell targets | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF] researchgate.net

[PDF][PDF] Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - researchgate.net
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets.

DE Furst, P Emery - Rheumatology (Oxford, England), 2014 - europepmc.org
Biologic therapies that target pathogenic cytokines such as TNF, IL-1β or IL-6 have greatly
improved the treatment of RA. Unfortunately, not all RA patients respond to current biologic …

[引用][C] Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

DE Furst, P Emery - Rheumatology, 2014 - Oxford University Press